R. Wapenaar

Articles

P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study

BJH - 2018, issue Abstract Book BHS, february 2018

A. Janssens MD, PhD, S. Snauwaert MD, PhD, R. Wapenaar , C. Van Bogaert , A. Smet , V. Seynhaeve

Read more

Top